Expertise in
17
conditions

Dr. Ahmed M. Awad

Internal Medicine
Kansas City Kidney Consultants PA
4320 Wornall Rd Ste 208, 
Kansas City, MO 
Accepting New Patients
Offers Telehealth
Expertise in
17
conditions
Kansas City Kidney Consultants PA
4320 Wornall Rd Ste 208, 
Kansas City, MO 

Overview

Ahmed Awad is a primary care provider, practicing in Internal Medicine in Kansas City, Missouri.

Dr. Awad is highly rated in 17 conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Acute Kidney Failure, Chronic Kidney Disease, and Renovascular Hypertension.

He is actively involved in clinical research, co-authoring 14 peer reviewed articles and participating in 7 clinical trials. Dr. Awad is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in MO

Hospital Affiliations

Ascension Via Christi Hospitals Wichita, Inc.
Saint Lukes North Hospital
Saint Luke's East Hospital
Saint Luke's South Hospital
St Lukes Hospital Of Kansas City

Languages Spoken

English
Arabic
Farsi
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Kansas City Kidney Consultants PA
4320 Wornall Rd Ste 208, Kansas City, MO 64111
Other Locations
Office
100 NE Missouri Rd Ste 204, Lees Summit, MO 64086

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Pilot Trial of Thymalfasin (Ta1) to Prevent COVID-19 Infection in Renal Dialysis Patients
A Pilot Trial of Thymalfasin (Ta1) to Prevent COVID-19 Infection in Renal Dialysis Patients
Enrollment Status: Completed
Publish Date: April 21, 2026
Intervention Type: Drug
Study Drug: Thymalfasin
Study Phase: Phase 2
A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS
Enrollment Status: Completed
Publish Date: April 17, 2026
Intervention Type: Drug
Study Drugs: Sparsentan, Irbesartan
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome
Enrollment Status: Terminated
Publish Date: September 11, 2025
Intervention Type: Drug
Study Drug: Iademirsen
Study Phase: Phase 2
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
A 52-week Open-label (Sponsor-blind), Randomized, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of Daprodustat Compared to Recombinant Human Erythropoietin in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Initiating Dialysis
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

14 Total Publications

Glucose Metabolism and Innate Immune Responses in Influenza Virus Infection: Mechanistic Insights and Clinical Perspectives.
Glucose Metabolism and Innate Immune Responses in Influenza Virus Infection: Mechanistic Insights and Clinical Perspectives.
Journal: Cells
Published: October 30, 2025
Similar Doctors
Expertise in
13
conditions
Dr. Patrick M. Moriarty
Internal Medicine
Expertise in
13
conditions
Dr. Patrick M. Moriarty
Internal Medicine

Medical Pavilion

2000 Olathe Boulevard, 
Kansas City, KS 
 (0.8 miles away)
913-588-1227
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Patrick Moriarty is a primary care provider, practicing in Internal Medicine in Kansas City, Kansas. Dr. Moriarty is highly rated in 13 conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH), and Defective Apolipoprotein B-100. Dr. Moriarty is currently accepting new patients.

Expertise in
43
conditions
Dr. Dushyant S. Dahiya
Internal Medicine
Expertise in
43
conditions
Dr. Dushyant S. Dahiya
Internal Medicine

Office

3901 Rainbow Blvd # 102, 
Kansas City, KS 
 (4.3 miles away)
913-588-6019
Languages Spoken:
English
See accepted insurances

Dushyant Dahiya is a primary care provider, practicing in Internal Medicine in Kansas City, Kansas. Dr. Dahiya is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Gastrointestinal Bleeding, Acute Pancreatitis, Endoscopy, and Colonoscopy.

Expertise in
75
conditions
Dr. Vikas Agarwal
Internal Medicine
Expertise in
75
conditions
Dr. Vikas Agarwal
Internal Medicine
Before you request

Mosaic Life Care At St. Joseph-Internal Medicine Plaza 2

901 Heartland Rd Ste 3800, 
Saint Joseph, MO 
 (51.8 miles away)
816-671-4800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Vikas Agarwal is a primary care provider, practicing in Internal Medicine in Saint Joseph, Missouri. Dr. Agarwal is highly rated in 75 conditions, according to our data. His clinical expertise encompasses Myositis, COVID-19, Takayasu Arteritis, Kidney Transplant, and Vertebroplasty. Dr. Agarwal is currently accepting new patients.

Frequently Asked Questions about Dr. Ahmed M. Awad

How do I make an appointment with Dr. Ahmed M. Awad?

You can book an appointment with Dr. Ahmed M. Awad by calling their office at 816-404-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ahmed M. Awad a top-rated expert for End-Stage Renal Disease (ESRD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ahmed M. Awad is classified as an Distinguished expert for End-Stage Renal Disease (ESRD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ahmed M. Awad specialize in?

While Dr. Ahmed M. Awad is a Internal Medicine, they have specific expertise in End-Stage Renal Disease (ESRD), Acute Kidney Failure, and Chronic Kidney Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Ahmed M. Awad participate in research or clinical trials?

Yes. Dr. Ahmed M. Awad has published 14 articles and abstracts on conditions like End-Stage Renal Disease (ESRD). You can view a list of Dr. Ahmed M. Awad's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ahmed M. Awad accept my insurance?

Dr. Ahmed M. Awad accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 816-404-1000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Awad's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 66 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile